Aptose Biosciences Inc.

NASDAQ: APTO · Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Aptose Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 955.27K 955.27K 955.27K 955.27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
117.97K 226.49K 582.59K 692.18K 689.71K 712.21K 456.25K 479.74K 504.04K 520.82K 583.12K 603.99K 614.9K 620.24K 457.79K 303.85K 153.13K
Gross Profit
-117.97K -226.49K 372.68K 263.09K 265.56K 243.06K -456.25K -479.74K -504.04K -520.82K -583.12K -603.99K -614.9K -620.24K -457.79K -303.85K -153.13K
Operating Income
-21.96M -26.26M -36.2M -40.68M -47.79M -52.12M -50.4M -48.98M -45.2M -42.6M -56.55M -57.88M -60.7M -65.45M -55.86M -57.79M -60.19M
Interest Income
236K 357K 397K 617K 850K 1.15M 1.38M 1.4M 1.19M 788K 409K 177K 89K 94K 109K 133K 226K
Pretax Income
-21.33M -25.43M -35.8M -40.29M -47.17M -51.21M -49.25M -47.58M -44.02M -41.82M -56.15M -57.7M -60.61M -65.35M -55.74M -57.66M -59.94M
Net Income
-21.33M -25.43M -35.8M -40.29M -47.17M -51.21M -49.25M -47.58M -44.02M -41.82M -56.15M -57.7M -60.61M -65.35M -55.74M -57.66M -59.94M
Selling & General & Admin
10.93M 11.14M 11.51M 12.67M 13.61M 15.58M 16.19M 16.21M 15.67M 14.5M 14.99M 15.19M 15.51M 19.43M 21.08M 23.21M 28.57M
Research & Development
11.02M 15.06M 24.64M 28.19M 34.36M 36.77M 34.42M 32.75M 29.51M 28.09M 41.52M 42.66M 45.15M 45.98M 34.75M 34.55M 31.58M
Other Expenses
3K n/a n/a n/a n/a n/a 18K 18K 18K 18K 34K 34K 34K 34K 35K 35K 35K
Operating Expenses
21.96M 26.26M 36.2M 40.91M 48.02M 52.36M 50.63M 48.98M 45.2M 42.6M 56.55M 57.88M 60.7M 65.45M 55.86M 57.79M 60.19M
Interest Expense
291K 207K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a 12K 12K -6K -6K -18K -18K n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
21.96M 26.26M 36.2M 40.91M 48.02M 52.36M 50.63M 48.98M 45.2M 42.6M 56.55M 57.88M 60.7M 65.45M 55.86M 57.79M 60.19M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
2.13M 5.6M 5.6M 5.6M 5.6M 6.63M 6.5M 6.23M 6.17M 6.16M 6.15M 6.15M 5.94M 5.94M 5.94M 5.94M 5.94M
Shares Outstanding (Diluted)
21.26K 950.45K 950.45K 558.5K 437.77K 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M 1.89M
EPS (Basic)
-5.43 -4.54 -6.06 -6.58 -7.55 -8.05 -7.87 -7.7 -7.15 -6.86 -9.34 -9.66 -10.21 -11.01 -9.39 -9.79 -10.62
EPS (Diluted)
-282.66 -43.99 -48.64 -47.37 -41.86 -27.07 -26.04 -25.16 -23.28 -22.12 -29.69 -30.51 -32.04 -34.55 -29.47 -30.49 -31.7
EBITDA
-20.71M -25M -35.97M -40.67M -47.76M -52.18M -50.46M -48.8M -45.01M -42.42M -56.42M -57.74M -60.55M -65.28M -55.86M -57.8M -60.21M
EBIT
-20.92M -25.22M -36.2M -40.91M -48.02M -52.36M -50.63M -48.98M -45.2M -42.6M -56.55M -57.88M -60.7M -65.45M -55.86M -57.79M -60.19M
Depreciation & Amortization
-109K n/a 328.04K 433.63K 445.63K 467.63K 454.59K 486K 511.8K 526.8K 589.25K 602.19K 613.11K 619.11K 610.65K 609.34K 610.63K